|
Volumn 32, Issue 8, 2000, Pages 2817-2819
|
Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
POLYCLONAL ANTIBODY;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DIABETES MELLITUS;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL SYMPTOM;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TRANSPLANTATION;
MALE;
PNEUMONIA;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTILYMPHOCYTE SERUM;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
PREDNISOLONE;
PROSPECTIVE STUDIES;
TACROLIMUS;
TIME FACTORS;
|
EID: 0034528342
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)01895-9 Document Type: Conference Paper |
Times cited : (1)
|
References (14)
|